Clinical AI Excellence Lead

Pfizer; San Diego (CA); Hybrid; USD 177,000 - 294,000; Full time

Benefits offered by this job

Hybrid work model

Competitive benefits

Job summary

Pfizer is seeking an executive leader to drive AI across the Clinical Development lifecycle, partnering with Oncology, Clinical Operations, Biostatistics, Data Science, Medical Affairs, Regulatory Affairs and Digital teams.

You will shape strategy, design and deploy AI-enabled solutions, ensure regulatory alignment, and scale innovative analytics across trials while advancing operational excellence and patient outcomes.

Qualifications

• MD or PhD with relevant pharmaceutical/healthcare experience.
• Experience designing and implementing AI or analytics in clinical research.
• Experience interacting with regulatory agencies on AI in development.

Responsibilities

• Provide strategic leadership for enterprise AI in Clinical Development.
• Identify opportunities to accelerate timelines and enhance decision-making with AI.
• Lead development of AI-enabled tools and governance frameworks.
• Collaborate with Regulatory Affairs and Quality on AI validation and risk management.
• Build and lead cross-functional teams across Oncology, Medical, Digital, and Operations.
• Engage externally in industry forums and with regulators on AI in drug development.

Skills

AI in Clinical Development

Regulatory interaction

Cross-functional leadership

Clinical development

GCP knowledge

Executive communication

AI governance

Education

MD with 4+ years pharma/healthcare

PhD in Life Sciences/Clinical Research/Data Science

MS in Life Sciences/Engineering

Job description

Pfizer is seeking an executive leader to drive AI across the Clinical Development lifecycle, partnering with Oncology, Clinical Operations, Biostatistics, Data Science, Medical Affairs, Regulatory Affairs and Digital teams.

You will shape strategy, design and deploy AI-enabled solutions, ensure regulatory alignment, and scale innovative analytics across trials while advancing operational excellence and patient outcomes.